Immunosuppressants

Immunosuppressants Companies (10)

Immunosuppressants News

Immunosuppressants Products (17)

  • Product Fingolimod 0.50mg Capsule

    Description: Oral immunomodulatory medication used primarily in the treatment of relapsing forms of multiple sclerosis. It helps reduce disease activity and progression.

    Therapeutic Category: Immunomodulator / Neurology

    Mechanism of Action (MOA): ...
  • Product Tacrolimus API

    Cerata Pharmaceuticals is the leading manufacturer of Tacrolimus API in IP/BP/USP/EP grade and offers high-quality products with the highest levels of compliance and our API products are trusted by pharmaceutical companies in over 90 countries, reflecting our global footprint and reputation.

    ...
  • Product avacopan

    Therapeutic Area: ANCA-Associated Vasculitis(AAV) ANCA

    Status: Early

  • Product Belumosudil

    Therapeutic Area: Immunology

    Status: Early

  • Product Apremilast

    Immunology APIIn house
    CN Status(A)
  • Product Everolimus

    Immunology APIEP, YBY
    CEP(Submitted), CN Status(A)
  • Product Sirolimus

    Immunology APIIn house 
    USDMF(Submitted), EDMF, CN Status(A)
  • Product Tacrolimus

    Immunology APIUSP, EP, IP
    USDMF(Submitted), CEP, CN Status(A)
  • Product Tacrolimus

    Immunosuppressant USDMS, CEP, JPDMF, China DMF, Canada DMF available for Tacrolimus.
  • Product Amoxicillin Sodium and Clavulanate Potassium 5:1 (Sterile)

    Amoxicillin Sodium and Clavulanate Potassium 5:1 (Sterile)
  • Product [2H12]-Cyclosporin A

    Cyclosporin A is intended for Pharmaceuticals applications. It is an immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection.
  • Product Ampoule, Vial & Bottle Manufacture & Fill

    Fully Integrated Manufacture & fill
  • Product Tacrolimus

    1. Purpose   - Immunosuppressant  

    2. Effects/Benefits   -  Primarily used to reduce the risk of organ rejection in patients with allogeneic organ transplantation. It is also used to treat autoimmune diseases, such as atopic dermatitis.  


    3. Ma...

Upcoming Events

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • CPHI Korea 2026

    COEX, Seoul, Korea
    25 Aug 2026 - 27 Aug 2026

Pharmaceutical Industry Webinars